Presolicitation
Modification to W81K0223P0126
W81K0223P0126
Department of the Army, W40M Mrco Pacific. In-Vitro Diagnostic Substance Manufacturing.
Awarded
$480,406.28 obligated so far on USAspending
Get the next one like this from Department of the Army by email, the day it is posted.Find my opportunities
This one was awarded in 2024
13 like it are open now in in-vitro diagnostic substance manufacturing
- Cost Per Reportable Result Purchase of Immunohistochemistry Reagents for Laboratory Tests.
Department of Veterans Affairs, 260-Network Contract Office 20
Sources soughtNAICS 325413Anywhere in the US36C26027Q0058Closes in 12 daysNov 13 - Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC
Department of Veterans Affairs, 260-Network Contract Office 20
Closes in 278 daysAug 6, 2027 - NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes tomorrowNov 2
Description
As published on SAM.gov.
The Medical Readiness Contract Office – Pacific, in support of Madigan Army Medical Center, Washington, intends to modify contract W81K0223P0126 with Sebia Inc to add 2 additional products and to adjust quantities for the following items, which are compatible with the Capillarys 3 Octa Analyzer for hemoglobin electrophoresis, serum electrophoresis, urine electrophoresis, serum immunotyping, carbohydrate deficient transferrin, and hemoglobin A1C testing:
Adding: (1) High CDT Control (2) Tubes/Caps for Controls Adjusting Quantities: (1) CAPI 3 HBA1C (2) HBA1C Capillary Calibrators (3) CAPI 3 Bins for Reagent Cups (4) Reagent Cups for CAPI3 (5) CAPI 3 Wash Solution (6) CAPI 3 Protein(E) (7) Normal Control- Agarose/Capillary (8) Hypergamma Control Serum (9) CAPI 3 IT (10) CAPI 3 Urine (11) IT/IF Control (12) HB A2 Normal Control (13) Pathological HBA2 Control (14) HGB AFSC Control- Agarose/Capillarys (15) CAPI 3 CDT (16) HB A2 Normal Control (17) Clean Protect This contract was awarded via sole source procedures.
The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other supplies or services will satisfy agency requirements. This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary, classified, confidential, or sensitive information should be included in your response.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Sebia, Inc.
- UEI
- WKVRJJ6G6VB5
- CAGE
- 1FRD3
- Vendor location
- Norcross, GA
- Contract
- W81K0223P0126, purchase order
- Obligated
- $480,406.28, current value $891,654, potential $1,127,460
- Actions
- 9 between August 1, 2024 and April 2, 2026
- Competition
- Not Competed, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- 0002 Base Capi 3 Hba1c Mod to Add Products, Increase/Decrease Quantities and Correct Unit Prices.
- Match
- solicitation number W81K0223P0126 was reused as the contract number; same awarding office W81K02 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
May 6, 2024
Presolicitation
Due May 14, 2024 at 8:00 PM EDT. SAM.gov, notice 8e3bed50f61e47edb88a1e31545da597
Points of contact
- Leslie Takayamaleslie.m.takayama.civ@health.mil